H. Au
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Pancreatic and Hepatic Oncology Research 6
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 3
- Cancer survivorship and care 3
-
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Malcolm J. Moore (9 shared papers)David Goldstein (3 shared papers)Wendy R. Parulekar (4 shared papers)Robert Lim (2 shared papers)J. Randolph Hecht (2 shared papers)Robert A. Wolff (2 shared papers)John Hamm (2 shared papers)Steven Gallinger (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Quality of Life Research (2 papers)Pancreatology (1 paper)Investigational New Drugs (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
H. Au
22 papers receiving 3.4k citations
H. Au's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 2.5k
- Cancer Research 669
- Pulmonary and Respiratory Medicine 671
- Epidemiology 319
- Hepatology 71
Countries citing papers authored by H. Au
This map shows the geographic impact of H. Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Au more than expected).
Fields of papers citing papers by H. Au
This network shows the impact of papers produced by H. Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Au. The network helps show where H. Au may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Au, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Hit paper breakdown → | 2007 | 2920 |
| 2 | 2008 | 127 | |
| 3 | 2009 | 122 | |
| 4 | 2009 | 74 | |
| 5 | 2004 | 58 | |
| 6 | 2011 | 38 | |
| 7 | 2014 | 28 | |
| 8 | Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer. | 2000 | 26 |
| 9 | 1999 | 22 | |
| 10 | 2007 | 18 | |
| 11 | 2023 | 16 | |
| 12 | 2009 | 13 | |
| 13 | 2016 | 12 | |
| 14 | 2007 | 11 | |
| 15 | 2011 | 6 | |
| 16 | 2014 | 5 | |
| 17 | 2006 | 4 | |
| 18 | 2011 | 2 | |
| 19 | 2008 | 2 | |
| 20 | 2006 | 1 |
About H. Au
H. Au is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Public Health, Environmental and Occupational Health and Economics and Econometrics, having authored 22 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer survivorship and care (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (669 citations), Pulmonary and Respiratory Medicine (671 citations), Epidemiology (319 citations) and Hepatology (71 citations). H. Au has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Malcolm J. Moore, David Goldstein, Wendy R. Parulekar, Robert Lim, J. Randolph Hecht, Robert A. Wolff, John Hamm, Steven Gallinger, David Walde and P. Murawa. Their work appears in journals such as Journal of Clinical Oncology, Quality of Life Research, Pancreatology, Investigational New Drugs and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.